ACBP: Scientists Identify Key Protein Driving Bone Metastasis, Pointing to New Therapeutic Strategies

Pembrolizumab Plus Enzalutamide Therapy Shows No Benefit in Metastatic Castration-Resistant Prostate Cancer Trial